WNK2 and melanoma: MAPK subtype: in melanoma patients, the MAPK (mitogen-activated protein kinase) pathway, is hyperactivated causing a cascade activation of NRAS, BRAF, MEK, and ERK (MAPK), intensifying the transcription of the genes involved in cell proliferation, growth, and mutation [1].